Relapsing fever and Lyme disease spirochetes of the genus Borrelia display at their surfaces abundant lipoproteins: Vmp proteins in Borrelia hermsii and Osp proteins in Borrelia burgdorferi. Vmp and Osp proteins largely determine serotype specificity, and neutralizing antibodies of infected or immunized animals are directed at them. For the present study, we examined B. hermsii serotype 33, which is unique among strain HS1 serotypes in the low frequency of switches to other serotypes during infections and in vitro cultivation. Failing to clone the complete vmp33 gene, we accomplished its further characterization by (i) determining three partial amino acid sequences, (ii) designing oligonucleotide primers based on these amino acid sequences, (iii) cloning and sequencing the central portion of vmp33, and (iv) using outwardly directed primers and the inverse PCR to clone the 5' and 3' ends of the gene and flanking regions. The transcriptional start site was identified by primer extension analysis. Vmp33 was a polypeptide of 211 amino acids; the three partial amino acid sequences were identified in the open reading frame. Vmp33 was found to be more similar to other 20-kDa Vmp proteins of B. hermsii and to OspC proteins of B. burgdorferi than it was to 35-to 39-kDa Vmp proteins of the same strain. Moreover, OspC proteins were more similar to Vmp33 than they were to OspA, -B, or -D proteins of B. burgdorferi. These sequence similarities were consistent with Western blot (immunoblot) findings of crossreactions between Vmp33 and OspC with anti-Vmp33 and anti-OspC sera. The promoter for the expressed vmp33 gene was found to be different from the expression site for other active vmp genes characterized to date.
The agents of relapsing fever and Lyme disease are spirochetes of the genus Borrelia. All members of this genus are host-associated parasites that cycle between vertebrate and arthropod hosts. In their hosts, these bacteria occupy various niches, including blood or hemolymph, neural tissue, and salivary glands (for a review, see reference (6) . Efficient and frequent transfer between vertebrate and invertebrate hosts is essential for sustained maintenance of borrelias in nature. Although the features of Lyme disease and relapsing fever differ in several respects, their agents have this requirement in common. Consequently, it is conceivable that relapsing fever and Lyme disease borrelias have similar pathogenetic mechanisms to achieve their aims.
Phylogenetic studies of the genus Borrelia have shown that the Lyme disease group of species can be further distinguished from the cluster of species that cause relapsing fever in North America at the level of DNA sequences for rRNA and flagellin genes (23, 26, 29) . There has been less comparative analysis of genes encoding surface proteins, which presumably would be under greater selective pressure from a host environment rich with antibodies and other immune effectors. If relapsing fever and Lyme disease agents have similar invasion mechanisms, a promising place to search for homologous virulence determinants is the cell surface. The sequences of four outer membrane lipoproteins, OspA, OspB, OspC, and OspD, of Borrelia burgdorferi and six alleles for the variable major protein, Vmp, of Borrelia hermsii have been determined (11, 14, 16, 20, 27, 31, 39) . The Vmp proteins are found in two size ranges: large, between 37 and 40 kDa, and small, between 19 and 22 kDa (3, 7, 31) . Both the large and small Vmp proteins are surface exposed (3, 4, 8, 9) . Whereas OspA, -B, and -D proteins are between 29 and 35 kDa, the OspC proteins are within the size range of the small Vmp proteins. OspC, like OspA, -B, and -D, is surface exposed (39) . Wilske et al. found evidence of antigenic cross-reactivity between the OspC protein of B. burgdorferi and a small Vmp of B. hermsii (39) . For the present study, we cloned and determined the sequence for the Vmp gene of B. hemnsii that was antigenically similar to OspC. In an analysis of this and other sequences of Osp and Vmp genes, we show that some Vmp proteins are members with OspC of a family of outer membrane proteins of the genus Borrelia.
MATERMILS AND METHODS
Strains and culture conditions. The origins of serotypes 3, 7, 17, and 24 of type strain HS1 of B. hernsii (ATCC 35209) have been described (7, 31) . Serotype 33 of strain HS1 was previously designated serotype C (4, 9, 25) ; the population of serotype 33 used in these studies was started from a single cell (9) . Isogenic variants B311 and B314 of strain B31 (ATCC 35210) of B. burgdorferi differ in their expression of OspA, -B, and -C; B311 is OspA+ OspB+ OspC-, and B314 is OspAOspB-OspC+ (34) . All borrelias were grown in BSK II broth and harvested by the methods described previously (2) . Cells were counted in a Petroff-Hauser chamber by phase-contrast microscopy. Escherichia coli JM109 (40) bearing plasmid pUC8 or recombinant plasmid pUC8-B31/ospCL+ (39) Antibodies. The origin of the anti-Vmp33-specific monoclonal antibody H4825 has been given (8); ascitic fluid was used for this study. Polyclonal rabbit antiserum to purified OspC of B. burgdorferi (35) was kindly provided by Tom Schwan, Rocky Mountain Laboratories. The origin of the polyclonal rabbit antiserum to purified Vmp33 (formerly VmpC) was described previously (4 added to a culture of 300 ml at a cell density of 106/ml. When the cell density reached 108/ml, the borrelias were harvested as described previously (2) and washed three times with 20 ml of RPMI 1640. Whole-cell lysates were subjected to polyacrylamide gel electrophoresis (PAGE) with 15% acrylamide as described previously (13 (10) . The final pellet was dissolved in trifluoroacetic acid, divided into aliquots, and then dried under vacuum. The Vmp33 fraction was treated either with endoproteinase Glu-C (Worthington) as described previously (10) or, after carboxymethylation, with endoproteinase Lys-C (Boehringer-Mannheim, Indianapolis, Ind.) (24) . The resultant mixtures of peptides were separated by PAGE and then transferred to polyvinyl difluoride membranes (Millipore Corp., Bedford, Mass.) (24, 27 Inverse PCR was performed essentially as described by Ochman et al. (28) . DNA at a concentration of 100,ug/ml was digested with a restriction enzyme. After another extraction of the DNA to remove the enzyme, the DNA was diluted 1:100 and the free ends were ligated with T4 DNA ligase at 15°C for 14 h. The ligation products were precipitated twice with ethanol, resuspended in 20 pL1 of water, and denatured at 94°C for 1 min. PCR was carried out for 40 cycles under these conditions: 94°C for 30s, 56°C for 30s, and 70°C for 2 min. The amplified product was ligated to the plasmid vector pCRII and transformed into EC Sure cells (Stratagene, La Jolla, Calif.). Plasmid DNA was extracted by using Qiagen Maxi columns (Qiagen, Chatsworth, Calif.).
DNA sequence analysis. The DNA sequences of inserts of recombinant plasmids were determined in both strands by double-stranded dideoxy sequencing with Sequenase version 2.0 (U.S. Biochemicals, Cleveland, Ohio) with standard M13 forward and reverse primers or custom synthesized primers (21, 27) . The transcriptional start site was identified by primer extension analysis of B. hermsii mRNA (5, 27) . Sequences were analyzed by using the Genetics Computer Group set of programs, specifically GAP for pairwise alignments of sequences, PILEUP for multiple alignment and estimation of genetic divergence between sequences (15), and PEPPLOT for prediction of regions of hydrophilicity and hydrophobicity by the Kyte-Doolittle algorithm (18) . The default parameters were used for these analyses. The BLAST program of Altschul et al. had been identified previously as lipoproteins (12, 14, 27) . To determine whether the Vmp33 was also a lipoprotein, borrelia cultures were radiolabeled with [3H]palmitate or treated with the signal peptidase II inhibitor globomycin, as was done in previous studies (12, 14, 27) . The leftmost two lanes in Fig. 1 show the Coomassie blue-stained proteins (CB) of serotype 33 in the gel and the [3H]palmitate-labeled proteins (Palm) of this serotype in the fluorograph. The (Fig. 2) . The location of Vmp33 in the blots is indicated by monoclonal antibody H4825, which is specific for Vmp33 (8, 33 was ligated to the plasmid vector, and the recombinant construct was transformed into E. coli. Three clones were sequenced over both strands by using custom primers that were based on data obtained on the first cloned insert. When this sequence was added to the first sequence, the sequence shown in Fig. 3 was obtained. An open reading frame began at nucleotide position +21 and ended at position 650; it would encode a polypeptide of 211 amino acids. The identity of this deduced protein with Vmp33 was confirmed by locating the three partial amino acid sequences within the open reading frame (Fig. 3) . A consensus signal peptidase II site (38) , FISC, was present at residues 16 to 19 of the open reading frame. The finding of a blocked N terminus in the attempt at sequencing the intact protein was consistent with acylation of the cysteine in a processed lipoprotein (12) . An 18-residue signal peptide is also consistent with the results of globomycin treatment shown in Fig. 1 ; the predicted size of the peptide is approximately the difference in sizes between the two bands in the globomycintreated cells.
Comparative sequence analysis of vmp33. Primer extension analysis (Fig. 4) identified the probable transcriptional site as a T, which was designated position + 1 (Fig. 3) . At positions 13 to -7 was the likely -10 promoter element (TAYTAAT (11, 16, 27, 39) and the other Vmp proteins of B. hermsii (14, 31) . The PILEUP algorithm was used to create the dendrogram shown in Fig. 5 . The length of the branches of the tree indicate the similarity score (18) , the scale for which is provided above the tree. The analysis revealed that Vmp33, Vmp3, and the two OspC proteins were more closely related to each other than they were to other outer membrane proteins of the same species. In other words, Vmp33 had greater sequence identity with OspC of B. burgdorferi than it did with Vmp7 or Vmpl7 of the same strain. Likewise, OspC was more similar to Vmp3 and Vmp33 of B. hermsii than it was to OspA, -B, or -D of the same strain.
The aligned DNA sequence identities determined by the GAP algorithm between the pairs vmp33-ospC, vmp33-vmp3, and vmp3-ospC were 61, 70, and 62%, respectively. The corresponding amino acid sequence identities were 48, 55, and 46%. Calculated sizes of Vmp33 and OspC of strain B31 cleaved of their presumed signal peptides are 19,620 and 20,287, respectively. The predicted isoelectric points of the processed proteins are 8.4 for Vmp33 and 7.4 for OspC of strain B31. A comparison of the mole percent compositions of the processed proteins of Vmp33 and OspC of strain B31 is given in the Table. Amino acid compositions of the two proteins are similar. Of note are the high lysine content and the absence of arginine and tryptophan in both proteins. Fig. 2 . The primer was annealed to the mRNA, and the DNA was extended with reverse transcriptase. The resulting primer extension product is in the leftmost lane and is indicated by an arrow. A dideoxynucleotide sequencing reaction using the same primer and the vmp33 gene as template was carried out in parallel to the primer extension analysis, yielding a sequence complementary to the coding strand. The locations of the upstream -35 (T1GA) and -10 (TATTAAT) promoter elements, a consensus ribosomal binding sequence (GGAGG), and the putative start codon (ATG) are indicated. For convenience, these designations refer to sequences that would be on the strand opposite to that shown under lanes G, A, T, and C.
When the sequences of Vmp33, Vmp3, and the OspC of strain B31 were examined more closely, a distinction between Vmp33 and other known Vmp proteins was found (Fig. 6 ). The sequences of Vmp3, -7, -17, -21, -24, and -25, while different for most of their lengths, have the same N termini for the unprocessed protein, MRKRISAII (14, 31) . In contrast, the deduced N-terminal sequence of the unprocessed Vmp33 was identical for 21 residues to the OspC of B. burgdorferi and other Lyme disease borrelias (39) . When this 21-residue conserved sequence was used as the search sequence with a BLAST survey with a percent accepted mutations (PAM) setting of 300 of the Swiss Protein and PIR protein data bases, the closest match (Poisson probability, 0.08) was with the 11 N-terminal residues (MKKKIISAILM) of the precursor of the secreted 45-kDa protein of Lactococcus lactis (37) .
At its C-terminal end, from position 164 to 211, Vmp33 was less similar to OspC than it was to Vmp3 but more similar to OspC than was Vmp3 (Fig. 6 ). For this region, the numbers of identical residues between the OspC-Vmp33, Vmp33-Vmp3, and OspC-Vmp3 pairs were 19, 26, and 10, respectively. Moreover, the ends of Vmp33 and OspC, like their beginnings, were the same. The dipeptide lysine-proline also terminates the OspC proteins of other Lyme disease borrelias (39) .
Plots of the predicted hydrophilic (negative values) and hydrophobic (positive values) regions of OspC of strain B31, Vmp33, and Vmp3 are shown in Fig. 7 emia in mice infected with serotype 33 than has been observed with other serotypes (3a, 7). The finding that unprocessed Vmp33 differs from other Vmp proteins at its N terminus suggests that Vmp33 in B. hermsii, like OspC in B. burgdorferi (34) , is expressed from a locus other than that expressed from other major lipoproteins characterized to date (5, 21, 31) . Consistent with this conclusion was the finding of a promoter region for vmp33 that was different from the expression site previously identified for vmp3, -7, -17, -21, -24, and -25 (5, 31) . However, if the expression site for vmp33 is different from that for other vmp genes, it is not clear why another Vmp protein is not expressed simultaneously. In contrast to the missing ospAB operon in some OspA-OspB-OspC+ mutants of B. burgdorferi (32, 34) , the genes for other Vmp proteins are not lost from serotype 33 cells (25) . Other mutants and strains of Lyme disease borrelias express OspC along with OspA (34, 39) . The findings suggest that, in B. hermsii, expression at one locus appears to influence the state of activation at another potential expression site. It appears that, when the previously described, and apparently dominant, expression site of serotypes 3, 7, 17, 21, 24, and 25 is active (14, 21, 31) , expression of the vmp33 gene is repressed at the level of transcription or otherwise altered posttranscriptionally.
